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Abstract: Face masks are devices worn over the mouth and nose to protect against splashes, infectious respiratory droplets, or aerosols
generated during breathing or coughing according to their filtering capacity. Medical masks, respirators, or cloth masks have been used
for source control and for the protection of the exposed. After the first case on March 11, 2020, in Turkey, National COVID-19 Scientific
Advisory Board published various contents for the correct use of masks. Medical face masks have been used in healthcare settings for
both source control and potential personal protection before the COVID-19 pandemic. Adverse events associated with using masks
are very sparse and mainly associated with tight-fitting respirators or dermatitis due to prolonged use and should not be a reason for
refusal to use. Studies suggest the use of masks mainly in the healthcare facilities but also in the community for source control of people
who have respiratory symptoms of communicable diseases other than COVID-19. They are likely to be acceptable if recommended,
particularly in more severe epidemics and pandemics. Metaanalysis, case control, cross sectional, cohort, retrospective, retrospective
cross sectional, research, randomized controlled, and controlled comparison studies were reviewed on the protective effect of masks on
COVID-19 with laboratory evidence. Optimum use of face masks with additional precautions has been found to be useful controlling
the spread of the respiratory viruses such as SARS-CoV-2 in most of the studies and metaanalyses. As a conclusion, the recent evidence
in COVID-19 pandemic is consistent with the previous studies which have shown association between face mask use and decreased risk
of viral infections, and medical face mask use should be encouraged both for the community and healthcare facilities along with other
infection control measures such as hand hygiene, during outbreaks when there is widespread community transmission.
Key words: COVID-19, efficacy, face mask, pandemic, SARS-CoV-2

1. Introduction
1.1. Properties of face masks
Face mask is a term used for a nonmedical/medical face
mask or a respirator which is worn over the mouth and
nose to prevent the splash and inhalation or release of
infectious respiratory droplets, or for harmful substances.
Types of face masks were demonstrated in Figure 1a
as elastomeric respirators, in Figure 1b as N95 filtering
facepiece, in Figure 1c as surgical mask, and in Figure
1d as cloth mask. Infectious respiratory droplets can be
generated by breathing, speaking, coughing, or sneezing
[1]. Masks can be used for source control or for the
protection of the wearer. Source control is when it is used
to prevent the spread of infectious respiratory particles
like droplets or aerosols, and it is for the protection of
others in the environment. Nonmedical face masks (e.g.,
cloth masks) used in community include many self-made
forms or commercial masks, including masks made of

disposable materials or textile which can be washed and
reused. Because of not being standardized, they are not
compatible for the use in healthcare facilities by healthcare
workers (HCWs). The main three categories of masks are
summarized in Table 1.
Medical masks or surgical masks are loose-fitting
disposable medical devices which can protect the users
from large respiratory droplets or splashes produced by
sneezing or coughing as physical barrier but not aerosols
and airborne infection [2,3]. They vary in thickness and
permeability. A medical face mask can also be used as
source control to stop the spread of large respiratory
droplets from the person wearing them [4]. Requirements
for medical face masks, including the duration of use, are
defined in the European Committee for Standardization’s
published standards. The EN 14683 standard, a European
standard, describes the requirements and test methods for
medical face masks. This standard has also been published
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in our country by the Turkish Standards Institute (TSE)
with the following title: TS EN 14683+AC Medical face
masks - Requirements and test methods.
Respirators are maintenance-free, tight-fitting
disposable personal protective equipment which are
classified according to European Union (EU) standard
EN 149: 2001 +A1:2009 or NIOSH USA standards.
They are designed to protect the wearer from airborne
microorganism exposure according to their types and
filtering degree. Filtering performance strongly depends
on fitting and different devices should be tested by HCWs
to find the best fitting size and model for their face. The
protection degrees of respirators are determined by their
filtering capacity of 0.3 µm and larger particles. According
to EU and US standards, the degrees of protection are
as follows; FFP1: 80%, FFP2: 94%, FFP3: 99%, and N95:
95%, N99: 99%, N100: 99.9%, FFP for EU and N for US.
An N95/N99 respirator is the United States is equivalent of
FFP2/FFP3 respirators in EU as defined by U.S. standard
NIOSH 42 CFR, part 84. The standard in question has
been published in our country by the Turkish Standards
Institute (TSE) with the following title: TS EN 149
Respiratory protective devices - Half masks with filters for
protection against particles - Features, tests and marking.

(a)

(b)

1.2. Potential adverse effects of face mask use
Wearing a face mask may cause anxiety and difficulty
in breathing and this may be seen more in people with
underlying respiratory or psychiatric disease. On the other
hand, it is not proven by scientific evidence that wearing
a face mask aggravates respiratory or other diseases [5,6].
Several studies did not find significant physiological effects
on people wearing a face mask even during intense exercise
[7–10]. However, there are a lot of cases reporting adverse
skin reactions, such as erythema and pruritus particularly
due to the extended use [11–14]. It is also important that
the tight-fitted face masks like respirators generally results
in problems of tolerability, discomfort, and headaches [13].
Communication breakdown is an additional problem that
masks may cause, especially among people with hearing
impairment, particularly because the missing speech
reading cues [16,17].
The availability of medical face masks may be limited
sometimes during the pandemic. This can cause high
costs or inappropriate reuse of masks which could result
in an increased risk of self-contamination or individuals’
incompliance with the policies [18].
It should not be forgotten that the production and
disposal of large amounts of face masks made of synthetic

(c)

(d)

Figure 1. Types of face masks. (a) Elastomeric respirators, tight fitted, half facepiece or full facepiece respirators made of synthetic or
natural rubber material, reusable. (b) An N95 filtering facepiece respirator is designed to achieve a very close facial fit and very efficient
filtration for airborne particles. (c) A surgical mask/medical face mask is a personal protective equipment worn by health professionals
during medical procedures. (d) A cloth mask, or a cloth face covering, which is not standardized or regulated1.
US FDA (2020). Use of respirators, facemasks, and cloth face coverings in the food and agriculture sector during coronavirus disease (COVID-19)
Pandemic [online]. Website: https://www.fda.gov/food/food-safety-during-emergencies/use-respirators-facemasks-and-cloth-face-coverings-food-andagriculture-sector-during-coronavirus [accessed 15 Feb 2021].
1
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Table 1. Summary of three main mask categories.
Masks

Characteristics

Advantages

Disadvantages

Respirators
(e.g., N95
masks)

· Protects from aerosols/droplets
· Made of 4 layers, usually polypropylene
and other materials
· Requires certification by authorities,
NIOSH in the US or equivalent
organizations in other countries
· EN 149: 2001 +A1:2009, TSE EN 149
standards for European Union and
Turkey retrospectively

· Designed to be tightly fitted and has a tight
seal
· High filtration efficiency
· Contains electrets to filter particles
electrostatically
· Recommended for healthcare workers
performing aerosol generating procedures
· May be oil resistant depending on model
· May be fluid resistant depending on
model, e.g., surgical N95

· Expensive
· Not readily available
· Designed for single use, or
when possible, complexity of
decontamination and reuse
techniques

Surgical
masks

· Prevents aerosol/droplet spread instead
of protecting the wearer
· Usually made up of 3 layers of meltblown polypropylene
· Approved by FDA, EN 14683, EN
14683+AC standards, but has a wide
variety of masks

· Cheap
· May use electrets
· Flame and fluid resistant
· No significant differences for H1N1
infection rate for healthcare workers
wearing either N95 or surgical masks

· Loose fitted
· Single use
· Not suitable for high-risk
environments and aerosol
generating procedures

· Made up of various fabrics (cotton,
silk, nylon, etc.)
· Not regulated by any agency

· Cheap and easy to produce
· Widely available for public
· Can be washed and reused,
· May use electrets, depending on material
used

· No standardization in design
and material
· Poor filtration efficiency and
may decrease by washing
· Not fitted
· Not recommended for
HCWS

Cloth
masks

materials due to universal mask use may have a detrimental
effect on the environment if not appropriately managed
[19].
The impact of using face masks should depend on
the prevalence of COVID-19 in the community. In
places without significant community transmission of
COVID-19, the potential harms and costs may outweigh
the benefits [19,20]. In implementing policies on the
widespread use of face masks for the prevention of
COVID-19 in the community, these potential barriers and
adverse effects should also be considered [21].
1.3. Mask use in Turkey
The first detected case of COVID-19 in Turkey of the
COVID-19 epidemic, which spread worldwide, was
announced by the Ministry of Health on March 11, and
the first death due to the virus occurred on March 15,
2020. At the beginning of April, in addition to the curfew
and other measures for certain age groups, masks were
made mandatory in public areas such as markets, and
it was decided to distribute masks free of charge. In this
period, brochures and informative films about the use of
medical and cloth masks in the society were prepared by
the National COVID-19 Scientific Advisory Board for the
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correct use of masks. Similarly, detailed instructions and
brochures on the use of medical masks and respiratory
masks in health institutions were prepared. Today,
compulsory use of masks in community continues along
with other measures.
2. Use of face masks in preventing influenza, SARS, and
other respiratory viral infections
Medical face masks have been used in healthcare
settings for both source control and potential personal
protection before the COVID-19 pandemic. They were
recommended mainly in the healthcare facilities but also
in the community for source control of people who have
respiratory symptoms of communicable diseases. They
are likely to be acceptable if recommended, particularly
in more severe epidemics and pandemics. However, face
masks may not be appropriate in some conditions such as
during sleep and it should not be forgotten that compliance
may be lower in some areas and particular groups.
The main uses of medical face masks were for
preventing the transmission of tuberculosis and influenza
as means of source control. The evidence of face masks in
preventing infectious diseases other than SARS-CoV-2 in
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the community and healthcare facilities are summarized
below [22,23].
2.1. Community
In a metaanalysis on efficacy of the use of face masks in
community by WHO, ten randomized controlled trials
(RCTs) were reviewed. Most of the trials investigated
the combined effect of face masks with improved hand
hygiene. In the pooled analysis, a 22% relative risk
reduction was found in laboratory-confirmed influenza
(RR: 0.78, 95% CI: 0.51–1.20, I2 = 30%, p = 0.25) in the face
mask group, and 8% reduction of in the face mask group
regardless of hand hygiene (RR: 0.92, 95% CI: 0.75–1.12,
I2 = 30%, p = 0.40), but the evidence was insignificant.
Low compliance in mask use was suggested to be reducing
their effectiveness. As a conclusion, they recommended
face masks to be worn by asymptomatic people in the
community in severe epidemics or pandemics due the
potential effectiveness of this measure, although there
was no evidence of them reducing transmission. They
concluded that there were important knowledge gaps in
the mechanisms of person-to-person transmission of
influenza and high-quality RCTs investigating the efficacy
of face masks against laboratory confirmed influenza were
needed [23].
Eight RCTs showed inconsistent and statistically
insignificant results. In two of the RCTs, a statistically
significant favorable effect was found in the subgroup
that included use of a medical face mask within 36 h from
symptom onset. In most of these RCTs, medical face masks
were used both by ill in means of source control and the
healthy susceptible people. It is difficult to distinguish if
the effect is related to personal protection or from source
control [24–28]. There was heterogenicity between studies
and deviations from interventions in several studies
such as compliance problems in the intervention groups
whereas several participants in the control groups were
using medical face masks in some studies [29,30].
Two case-control studies investigated the transmission
of SARS in the community and statistically significant
effect was detected in favor of the use of face masks. (OR
0.3–0.36). A cross-sectional study also demonstrated a
favorable but not statistically significant effect [31–33].
Another recent metaanalysis including RCTs and casecontrol studies suggests enough evidence for medical
masks’ effectiveness in community to prevent transmission
of respiratory viral infections. This metaanalysis showed
a significant effect of medical mask use in preventing the
transmission of respiratory infections, including SARSCoV-2 (OR = 0.66) with or without other interventions.
Subgroup analysis which includes only RCTs also
demonstrated significant protection of medical facemask
in preventing influenza and influenza-like illness (ILI)
(OR = 0.71 and OR = 0.70, respectively) [34].

Medical mask use in community should be strongly
encouraged in outbreaks, particularly when there is
widespread community transmission and where physical
distancing could not be provided. However, face masks
should not be a replacement for other public health
measures such as physical distancing or hand hygiene.
2.2. Healthcare settings
According to a metaanalysis by Offeddu et al. [2] which
included 6 RCTs and 23 observational studies, in RCTs
masks and respirators provides statistically significant
protection against ILI (RR = 0.34) and clinical respiratory
illness (CRI) (RR = 0.59). Only two RCTs investigated
the respiratory infection risk in healthcare workers
(HCWs) wearing personal protective equipment (PPE)
continuously and not wearing PPE for control group
[35,36]. The metaanalysis suggested a protective effect
against viral infections which were laboratory-confirmed
but it was insignificant. N95 respirators demonstrated
greater and statistically significant protection against CRI
(RR = 0.47) and laboratory-confirmed bacterial infection
(RR = 0.46), but no superiority for viral infections or ILI
when compared to masks [2].
Protective effect for masks against severe acute
respiratory syndrome (SARS) was reported by most of
the case-control studies. Four out of the five case-control
studies demonstrated a favorable statistically significant
effect (adjusted OR range: 0.08–0.29) [32,37–40]. Cohort
studies reported less pneumonia and moderate protection
against SARS-CoV infection which was laboratory
confirmed. Metaanalysis of these observational studies
provided evidence of significant protective effect against
SARS (OR = 0.13 for masks and OR = 0.12 for respirators).
There was no significant difference between N95
respirators and medical masks in means of protection of
HCWs from SARS [2].
Early in the outbreak of H1N1 pandemic in 2009, the
effect of masks and respirators was investigated in HCWs.
Pandemic H1N1 seroconversion was 21% (9/43) in HCWs
treating H1N1 patients without respiratory PPE and 0
% in others [41]. Similarly, in a cohort study from Hong
Kong, HCWs using medical masks during whole patient
contacts remained healthy. In two matched case-control
and two cross sectional studies, no association was found
between compliance with respiratory PPE use and pH1N1
infection [2].
A recent RCT investigating difference of the preventive
effect between N95 and medical masks, among outpatient
health care personnel, revealed no significant difference in
the incidence of laboratory-confirmed influenza [42].
There is evidence supporting medical mask use in
medical facilities as part of the infection control programs
to mitigate the risk of CRI and ILI among HCWs and N95
respirators may have greater protection. Medical masks
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and respirators are also found effective for SARS but not
for H1N1.
3. SARS-CoV-2 and masks
A total of 12 studies, including metaanalysis, case control,
cross sectional, cohort, retrospective, retrospective cross
sectional, research, randomized controlled, and controlled
comparison studies, conducted in China, United Kingdom,
USA, Thailand, Uganda, Ethiopia, South Korea, Canada,
and Iran were reviewed on the protective effect of masks on
COVID-19 [43–49]. All patients had laboratory evidence
of SARS-CoV-2. The researchers investigated healthcare
workers, nonprofessional populations, and contacted
people in these articles. Most of the studies revealed that
optimum use of face masks with additional precautions
controlled the spread of the respiratory viruses such as
SARS-CoV-2. Most of the studies were retrospective and
demonstrated in favor of using mask in healthcare settings,

but only RCT failed to show efficacy. The summary of the
studies is demonstrated in Table 2.
The metaanalysis by Chu DK et al. investigating use of
surgical masks among other measures supports physical
distancing of 1 m or more. Face mask use was found to be
related with a great reduction of infection risk (n = 2647;
aOR: 0.15, 95% CI: 0.07 to 0.34). Stronger associations were
found with respirators compared with surgical/medical
masks. Eye protection was also found to be associated with
less risk of infection [50].
Another metaanalysis of 21 studies suggests that mask
use provides a statistically significant protective effect (OR
= 0.35). Mask use by HCWs and public can decrease the
risk of respiratory virus infection by 80 % (95% CI = 0.11–
0.37) and 47 % (95% CI = 0.36–0.79). Protective effect of
mask wearing was higher in particular regions of the world
than others (in Asia OR = 0.31, in the Western countries
OR = 0.45). Masks had a protective effect against SARS-

Table 2. The summary of studies on the effectiveness of face masks for SARS-CoV-2 infection.
Study

Country

Population

Study design

The type of
mask

Other preventive
Results
applications

Wang et al.
2020

China

Healthy workers
(doctors and nurses)

Retrospective

N95

Reduction in the infectious
Disinfection and
risk of 2019-nCoV in
hand washing
doctors and nurses

Bundgaard
et al.
2020

Adults outdoor more
than 3 h per day
Randomized
Denmark
without occupational controlled trial
mask use

Ma et al.
2020

China

Experimental

China

Chinese citizens
living in Iran
and subsequently
evacuated

Thailand

Asymptomatic
contacts of
COVID-19 patients

Fan et al.
2020

Doung-ngern
et al.
2020

Mboowa et al.
Uganda
2021

Natnael et al.
2021
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Ethiopia

Surgical
mask

-

Surgical masks in addition
with other public measures
did not reduce the SARSCoV-2 infection rate

Research
article

N95, surgical
mask, cotton
mask

Hand hygiene

Wearing effective masks and
hand hygiene, may slow the
rapid spread of the virus

Cohort

Surgical
mask

Restricting gatherings and
wearing facemasks can
Travel restrictions
decrease transmission of
COVID-19

Surgical
mask

Handwashing
and social
distancing

Case control

High risk individuals
(polices, market
Retrospective
Face mask
workers, healthcare
Cross sectional
workers)

Taxi drivers

N95, surgical
Cross sectional mask, cotton
mask

Wearing masks,
handwashing, and social
distancing in public is
suggested to protect against
COVID-19

Face masks in healthcare
Health education and community settings
programs
prevent the transmission of
COVID-19

-

Prevalence of mask wearing
among taxi drivers was low.
The significantly associated
factors were determined
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CoV-2 (OR = 0.04) along with other respiratory viruses;
influenza (OR = 0.55), SARS (OR = 0.26). They concluded
that masks can be helpful as an adjunctive method in the
COVID-19 outbreak [51].
Fourteen studies were included in the metaanalysis from
the UK. While observational and preclinical studies finding
significant benefit of mask use in preventing SARS-CoV-2
transmission RCTs failed to demonstrate this effect. Eleven
of RCTs studying other respiratory diseases than SARSCoV-2 found no significant benefits for either ILI or viruses
which were laboratory confirmed. Only one RCT found a
significant benefit of surgical masks over cloth masks. They
emphasized the need for evidence from RCTs which reports
outcomes such as compliance and comfort [52].
Four articles of a total of 7688 participants were
included in a recent metaanalysis. The result has shown a
significant decrease in infection with face mask use (the
pooled RR = 0.12 95 %CI [0.06, 0.27] P < 0.001). The main
limitation of this metaanalysis is that studies included had
nonrandomized designs [53].
Eventually, a metaanalysis comparing N95 and medical
mask use among HCWs showed that continuous wearing
of N95 respirators may have the best protection against

viral respiratory diseases. According to researchers,
surgical masks needed to be replaced frequently for better
efficacy. They concluded more RCTs during this COVID-19
epidemic were needed for further analysis.
4. Conclusion
As a conclusion, the recent evidence in COVID-19
pandemic is consistent with the previous studies which have
shown association between face mask use and decreased
risk of viral infections, and medical face mask use should
be encouraged both for the community and healthcare
facilities along with other infection control measures such
as hand hygiene, in the course of outbreaks when there is
widespread community transmission.
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